BRIEF-BBI Life Sciences says Sangon Health Sci-Tech entered into investment agreement with shareholders of Tianjin Hengjia Boitech Development

March 6 (Reuters) - Bbi Life Sciences Corp-

* VIE company of company entered into an investment

agreement with shareholders of Tianjin Hengjia Boitech

Development Company Limited

* Sangon Health will obtain 34% equity interest Of Tianjin

Hengjia by investment, with increase in capital amount of rmb6

million.

Source text for Eikon:

Further company coverage: